Division/Committee: [CHAS: Division of Chemical Health and Safety] [MEDI: Division of Medicinal Chemistry]

As the therapeutic potential of Cannabis sativa and its derivatives garners increasing scientific interest, the intersection of cannabis research and medicinal chemistry presents a fertile ground for innovation. This symposium aims to explore the evolving alliance between these fields, highlighting advancements in the discovery, characterization, and application of cannabinoids and related compounds in medicine. We invite contributions that delve into: Synthetic and natural product chemistry of cannabinoids and terpenoids Structure–activity relationships and drug design targeting the endocannabinoid system Analytical methodologies for quality control and standardization of cannabis products Pharmacokinetics, pharmacodynamics, and bioavailability studies Clinical and preclinical research on cannabinoid-based therapeutics Regulatory science and safety assessments in cannabis-derived drug development This symposium seeks to foster interdisciplinary collaboration, bringing together researchers from academia, industry, and regulatory bodies to share insights and drive forward the science underpinning cannabis-based therapeutics.

Nicole Goodwin

Merck & Co Inc

Appearances